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Reply
The comments are well taken . However
. the main purpose of the
report was to focus attention on the effect of antiarrhythmic medi-
cation on atrial fibrillatory activity where dramatic us aaes ware
observed with each of the antiarrhythmic medications . Clearly,
propifenone as administered had a good eleclrophysioloeic effect
even with the regimen used. We did not intend to rigorously
compare procainamide and propafenone but merely used each drug
as an example in (heir class .
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Risk Stratification for Arrhythmic Events
in Postinfaretion Patients Based on Heart
Rate Variability
Fslrell et at. (I) described the value of heart rate variability from
24-h ambulatory ECG recordings taken I week after infarction, This
heart rate variability combined with late potentials or repetitive
ventricular forms from the same Holler monitor seems to have a
high prognostic importance in identifying approximately 1!114 of
these early surviving postinfarction patients who are at a much
higher risk of developing a life-threatening
arrhythmia
event . 11 will
be hard to disregard these results in a prospective trial evaluating
any antiarrhythmic dmg in this patient population.
Because this measure of heart rate variability, calculated as the
base width of the main triangle that constitutes the RR interval
frequency distribution curve (Appendix of 1111
.
is so specific and
sensitive in defining this small population at high risk, the units that
are used to express this base width variation of RR intervals should
be correct. As described in their original report describing the
technique (2), this triangular interpolation method in 20 patients of a
similar population that did have an arrhythmic event averaged
258 ms, in agreement with a recent abstract 131 in 385 postinfarction
patients describing the sensitivity and specificity of this heart rate
variability method for values between 156 and 305 ms . In contrast,
a criterion of <20 ms is given by Farrell et al . (1) for similar patients
with impaired heart rate variability .
The incorrect values of base width heart rate variability in (I I arc
easy to explain
. As the authors themselves pointed out in the
Appendix, the RR intervals are measured on a discrete scale in steps
of 11128 s . This 11128 s is specific for their particular computer-based
analysis system and is determined by screen resolution and (lime-
dependent) QRS complex enlargement. The original base width
calculations are therefore in the first instance obtained in units of
7.815 ms and it seems to be exactly this factor that was forgotten to
he taken into account . To obtain the correct heart rate variability
base width, all results of this variable in 11) should be multiplied by
7.8125. This means that the summary and conclusions should be that
impaired heart rate variability is defined as having a base width
variability of < (56 ms.
Allematively, it is also possible that the bean rate variability in
(1) was actually determined by the "triangular index" method .
which
is
describ .,! in their earlier paper (4) and is identical to
"method C" in (2). The best prognostic variable for serious arrhyth-
mic ascots in 141 was this hears rate vanalnlrty index of <25 . This
trion^-ular index, which was not given any units, eon in the same way
easily be transformed into base width by multiplication by 2 x
i vi?i those a Iriorgle arearheight = 2 x triangular index in
units of 1,I'-8 U . Not surprisingly . this transformed triangular index
base width. v:hcn recalculated from C) . agrees excellently with the
unanguhv in crpolation base width values . except for I of the 40
described patlevts : P19. The listed value of 125 ms as base width
(method El is clearly an underestimation of [me heart rate variabil-
ity as visual!v can he seen from Figure I in (2). The transformed
meth., C oa
:r width for P19 is 304 me and points out that there is
a polenti ;d problem with the tdangodar interpolation medwd when-
ever the frequency distribution curve happens to be bimodal
.
This himodality actually happens quite often as it is merely the
consequence of the different day-versus nighttime basic rhythms .
Because it has been shown that heart rate variability is highest at
night, except possibly for those patients with vastly impaired heart
rate variability
(5
.6)
.
The nighttime variability might be of an even
higher prognostic value, and at the same time it would standardize
the different activity levels among patients loll sleeping) and
prob-
ably
prevznr the oecuactice of bimodal frequency distribution
v s . I wonder whether the authors have ever looked at this
prognostic value of nighttime heart rate variability!
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Mitral Commissurotonky in India
1 he article by Hickey et at, III detailing the results of surgical mitral
commissurotomy is an eye-opener in this era of a progressive trend
toward open mhral commissurotomy for all patients with mitral
stenosis /2
.31. In this letter we describe the shun-term re~Jlts of
mitral commissurotomy . as determined echocardiogmphically, in
patients with mitral stenosis .
Over the past 2 years 163 patients unaerwent open or closed
mitral commissurotomy at this institution and were assessed in
detail echocardiographically. The distribution was nonrandomized.
with a definite bias toward the open procedure in patients with
severe forms of subvalvular fusion . The main differentiating factor,
in a poor country like ours, was financial constraint . There were 137
palicets (47 male . 90 female) with pure critical mitral stenosis : the
mean age ores 26 years in the open commissurotomy group and 25 .5
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years in the closed commissurotomy group (n = i05)
. The preoper-
ative features were similar in both groups with respect to valve
involvement, subvalvular pathology and pulmonary artery pressures
(as predicted by echocardiography). The closed commissurotomy
group had a good result of valvotomy (mitral valve area, 2.3 t 0.52)
and compared favorably with the open commissurotomy group
(mitral valve area, 2 .52 t 0.56) (p = NS), and in all other variables
the two groups were similar . Mitral regurgitation occurred with
equal frequency in the groups with open and closed commissar
.
otomy (68% vs . 66%) although the group with tire closed procedure
had more patients with significant mitral regurgitation (9 .3% vs .
11 .3%) . In both groups mitral regurgitation occurred in patients with
more severe subvalvular fusion . Chordal tear, laceration and partial
tear of the papillary muscle, cusp avulsion were more often seen in
patients undergoing closed commissurotomy (9 .8%). All of these
patients had severe subvalvular fusion .
This is only a preliminary report and more detailed analysis and
follow-up are necessary before a definite conclusion can be reached .
However, we still believe that the closed procedure has a place
today, at least in financially indigent populations . The only watch
word is to choose the appropriate patient carefully .
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Diltiazem and Mortality in
Myocardial Infarction
In their review article, Bakris and Frohlich (I) state that the calcium
channel blacker dilliazem reduces mortality in patients with non
Q-wave myocardial infarction. The reference cited does not support
their view.
Compared with the established protective effects of a beta-
blacker in prolonging life and reducing recurrence of nonfatal
myocardial infarction in survivors of acute myocardial infarction,
none of the currently used calcium channel blockers (verapamil,
nifedipine, dilliazem) has been shown to be as favorable . Further-
more, a trial usingdiltiueem in patients with non Q-wave myocardial
infarction (2) (the reference cited by Bakris and Frohlich) showed no
reduction in mortality. Moreover, the Multicenter Diltiazem Postin
.
farctioe Trial (3) showed no difference in mortality between patient
groups. On the contrary, the subgroup of patients with left ventric-
ular dysfunction did worse with dilliazem
.
From the currently available data it may be concluded that the
prophylactic use of calcium channel blockers including dittiazem to
improve survival after myocardial infarction cannot be recom-
mended at this time
.
GEORGE BITTAR, MD
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Reply
Bittar is correct that the reference we cited did not present infor-
mation concerning deaths related to non-Q wave infarction in
patients with hypertension
. We included reference to the original
paper on the Multicenter Diltinzem Postinfaretion Trial because it
detailed the study design . Not included were details of a paper
whose data we heard presented at a national meeting
. We had
planned to cite that paper on the return of proofs to us, but it was not
yet published. The paper by Moss et al . (I) is now published
presenting data demonstrating an overall reduction in cardiac deaths
or nonfatal recurrent myocardial infarction in patients treated with
diltiazem, results not observed in placebo-treated patients or pa-
tients without a history of hypertension . We are pleased to add this
reference in support of our statement
. It underscores the sometimes
lengthy delay from presentation of new information to publication .
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